FBXW7 and acute lymphoblastic leukemia: Nevertheless, miR223 is a target of Notch but contributes greatly to T-ALL development, either suppressing FBXW7 or targeting ARRB1 (Arrestinb1) to impact on Notch degradative pathways [77,78,79].